Effects of nicotine administered via a transdermal delivery system on vigilance: a repeated measure study

Abstract Fifteen 18- to 25-year-old male smokers were tested in a within-subjects design to determine the influence of a transdermal patch of 21 mg nicotine on vigilance. Subjects were tested on the RVIP test (Rapid Visual Information Processing test) 1.30, 3.00 and 6.30 h after patch application, to verify the involvement of the dose of nicotine on the performance. This study confirms and extends the increasing effects of nicotine on vigilance previously found with orally and transdermally given nicotine. Moreover, it showed that such performance was independent of the time of nicotine absorption (1.30, 3.00 and 6.30 h after patch application), which suggests that a relatively low dose of nicotine suffices to activate vigilance processing. Regarding motor performance, no convincing effect of nicotine was observed on reaction time.

[1]  M. Posner,et al.  The attention system of the human brain. , 1990, Annual review of neuroscience.

[2]  J. McCarten,et al.  Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety , 1995, Pharmacology Biochemistry and Behavior.

[3]  C. Frith,et al.  A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory , 1996, Neuropsychologia.

[4]  R. West,et al.  Effects of nicotine on finger tapping rate in non-smokers , 1986, Pharmacology Biochemistry and Behavior.

[5]  Jack E. Henningfield,et al.  Nicotine and Smoking: A Review of Effects on Human Performance , 1994 .

[6]  Russell Ma.  Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. , 1988, Progress in clinical and biological research.

[7]  K. Perkins,et al.  Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  S. Stone-Elander,et al.  Cerebral effects of nicotine during cognition in smokers and non-smokers , 1998, Psychopharmacology.

[9]  M. Raw,et al.  Clinical use of nicotine chewing-gum. , 1980, British medical journal.

[10]  K. Wesnes,et al.  Effects of smoking on rapid information processing performance. , 1983, Neuropsychobiology.

[11]  N. Sherwood,et al.  Effects of nicotine on human psychomotor performance , 1993 .

[12]  B. J. Winer.  Statistical Principles in Experimental Design , 1992 .

[13]  A Gale,et al.  Evidence of more rapid stimulus evaluation following cigarette smoking. , 1985, Addictive behaviors.

[14]  A. Parrott,et al.  Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks. , 1992, Neuropsychobiology.

[15]  M. A. Russell.  Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. , 1988, Progress in clinical and biological research.

[16]  J. Devane,et al.  Clinical and pharmacokinetic properties of a transdermal nicotine patch , 1990, Clinical pharmacology and therapeutics.

[17]  M. Posner,et al.  Localization of cognitive operations in the human brain. , 1988, Science.

[18]  L B Sheiner,et al.  Pharmacodynamic model of tolerance: application to nicotine. , 1988, The Journal of pharmacology and experimental therapeutics.

[19]  N. Benowitz,et al.  Disposition kinetics and effects of intravenous nicotine , 1980, Clinical pharmacology and therapeutics.

[20]  D. Warburton,et al.  Evaluation of the information processing and mood effects of a transdermal nicotine patch , 1998, Psychopharmacology.

[21]  N. Benowitz,et al.  Stable isotope method for studying transdermal drug absorption: The nicotine patch , 1991, Clinical pharmacology and therapeutics.